Showing results (561-570 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|February 24, 2025
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate dataDavid A Jolliffe, Carlos A Camargo, John D Sluyter, et al.
The Lancet. Diabetes & Endocrinology|September 1, 2024
Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in SingaporeTheresia Mina, Wubin Xie, Dorrain Yanwen Low, et al.
The Lancet. Diabetes & Endocrinology|June 27, 2024
Early pregnancy HbA1c as the first screening test for gestational diabetes: results from three prospective cohortsPonnusamy Saravanan, Mohan Deepa, Zain Ahmed, et al.
The Lancet. Diabetes & Endocrinology|December 13, 2022
Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional studyJenneke E van Atteveld, Demi T C de Winter, Vincent G Pluimakers, et al.
The Lancet. Diabetes & Endocrinology|November 25, 2019
Physical activity and skeletal health in adultsJane A Cauley, Lora Giangregorio
The Lancet. Diabetes & Endocrinology|February 9, 2019
Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trialEdward Fottrell, Naveed Ahmed, Joanna Morrison, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2018
Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)John P Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, et al.
The Lancet. Diabetes & Endocrinology|October 6, 2018
Epidemiology and determinants of type 2 diabetes in south AsiaAndrew P Hills, Ross Arena, Kamlesh Khunti, et al.
The Lancet. Diabetes & Endocrinology|July 2, 2017
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trialDavid Z I Cherney, Bernard Zinman, Silvio E Inzucchi, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2018
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudiesBryan Williams, Thomas M MacDonald, Steve V Morant, et al.
Pageof 93